Reaction
Cytomegalovirus Oesophagitis reporting signals
As of the last recalculation, Cytomegalovirus Oesophagitis appears in 361 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 340.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 60 | 340.0 | 341.6 |
| Valganciclovir | 76 | 294.1 | 295.3 |
| Valganciclovir Hydrochloride | 76 | 294.1 | 295.3 |
| Ganciclovir | 39 | 246.2 | 247.1 |
| Ganciclovir Sodium | 40 | 245.0 | 245.9 |
| Mycophenilic Acid | 25 | 74.7 | 74.7 |
| Anti-Thymocyte Globulin (Rabbit) | 10 | 73.5 | 73.6 |
| Mycophenolate Mofetil | 114 | 70.3 | 70.3 |
| Mycophenolate Mofetil Hydrochloride | 114 | 70.1 | 70.2 |
| Tacrolimus Ointment 0.1% | 97 | 61.0 | 61.1 |
| Tacrolimus Extended-Release Capsules | 97 | 60.9 | 60.9 |
| Tacrolimus | 106 | 54.8 | 54.9 |
| Mycophenolic Acid | 27 | 52.5 | 52.5 |
| Sirolimus | 10 | 44.0 | 44.0 |
| Bendamustine Hcl | 11 | 42.2 | 42.2 |
| Everolimus Tablets | 11 | 39.0 | 39.0 |
| Efavirenz | 6 | 31.5 | 31.6 |
| Cisplatin | 36 | 29.4 | 29.4 |